Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

GLOBULIN SERUM, ANTI-HUMAN

Awarded
SPE2DS-26-T-307TFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

GLOBULIN SERUM, ANTI-HUMAN is a medical supply item intended for the detection of human IgG bound to red blood cells, packaged in 10 mL vials with a unit of issue of one vial per VI. The product requires refrigerated storage between 2 to 8 degrees Celsius and must have a non-extendable shelf life of 12 months, with no more than one month elapsed between the date of manufacture and the date of delivery to the government. All labels must include the date of manufacture, expiration or retest date, contract number, and lot number, with shelf-life markings strictly compliant with the latest revision of MMS1C. Packaging and marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and each unit must be sealed in a protective container within commercial shipping packaging suitable for safe delivery by common carrier at the lowest cost to the destination, which is APO, Korea with ZIP code 96260-5479. Delivery is FOB destination, with inspection and acceptance performed at the point of delivery, and the item must be delivered within 84 days after award. The contract falls under the NAICS code 621410 and is administered by the Department of Defense through the Medical Supply Chain MD Surg FSF. All submissions must be made electronically via the DLA Internet Bid Board System with a response deadline of August 10, 2026. Payment processing is managed through Wide Area WorkFlow (WAWF), requiring electronic invoicing with an Invoice and Receiving Report for fixed-price line items. The item is governed by a series of FAR and DFARS clauses including safeguards for covered defense information, cybersecurity requirements per NIST SP 800-171, restrictions on hazardous materials, export controls, whistleblower protections, and prohibitions on certain telecommunications equipment. The contractor must comply with hazardous material labeling standards, provide Safety Data Sheets if applicable, and ensure no covered defense telecommunications equipment is used unless exempted. The total estimated contract value is $5,996.00 across multiple line items, all identified by NSN 6550-01-242-2234. Offerors must provide a Unique Entity Identifier and CAGE code and certify their size status, including any socioeconomic designations, with affirmative responses triggering additional disclosures under the covered defense telecommunications clause.

General Info

Globulin Serum, Anti-Human, 10 mL vial, refrigerated, 12-month shelf life, labeled per MIL-STD-129 replacement, shipped to APO 96260-5479, NSN 6550-01-242-2234.

Contract Value

$92

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2

Purchase Order SPE2DS-27-P-0046

PDF, High priority: read this firstaward
High

RFQ SPE2DS-26-T-307T Medical Supply Chain

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Solicitation

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
Contacts1 person available
OfficeUSA
Office AddressUSA

Full Description

Show more
DLA award SPE2DS27P0046 posted on DIBBS. Awardee: SZY HOLDINGS, LLC (CAGE 0AG09) Total Contract Price: $92.00 Award Date: 10-05-2026 Solicitation: SPE2DS-26-T-307T Line items: - GLOBULIN SERUM, ANTI-HUMAN (NSN/Part 6550012422234, PR 7017749964)

Similar Contracts

Same NAICS industry code

NAICS: 325414
DIBBS
JAPANESE ENCEPHALIT
Solicitation # SPE2DP-26-R-0001
The Defense Logistics Agency Troop Support is soliciting Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringes under solicitation SPE2DP-26-R-0001, with a sole source justification under FAR 6.302-1 due to the unique nature of the product and regulatory requirements. The acquisition will follow Part 12 procedures for commercial items, resulting in a firm-fixed-price, indefinite delivery, indefinite quantity contract with an 18-month base term. The minimum order is 277,760 units, with an estimated and maximum quantity of 277,760 and 394,240 units respectively. Vaccines must be FDA-approved prior to the solicitation’s closing date and must comply with MPID Number 5 dated July 23, 2024. All deliveries are FOB destination to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, with a 120-day production lead time following issuance of each DD1155 delivery order. Inspection and acceptance occur at the delivery point, and the contractor is responsible for certification of conformity with all specifications including FDA regulations and labeling requirements. All packaging, marking, and labeling must adhere to strict government standards including MIL-STD-2073-1 for preservation, MIL-STD-129 for shipping labels, and MIL-STD-130 for item identification. Units must be marked with the NSN, CAGE code, part number, contract number, preservation method and date, and transaction control number, with commercial preservation denoted as “COMM’L” and military as “M” followed by the method and date. Intermediate and exterior containers require bar codes compliant with DoD logistics standards, and hazardous materials necessitate a Shipper’s Declaration for Dangerous Goods and Safety Data Sheets. Shelf life must include at least 12 months remaining at time of delivery for Type I items, with expiration and manufacture dates clearly marked. Each shipment must include a destination label addressed to DODAAC SV3100, and all documentation must be in English using durable, legible markings. The contract requires electronic submission via the DIBBS portal and prohibits paper solicitations. Contractors must maintain inspection records for three years post-delivery and comply with all applicable federal regulations including the Federal Food, Drug, and Cosmetic Act and 49 CFR for hazardous materials. No socioeconomic set-asides apply,
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

7 days ago

DEADLINE

in 24 days
View Details
NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

13 days ago

DEADLINE

in 28 days
View Details
NAICS: 325414
DIBBS
MEDICAL PHARMACY EMERGENCY NON NSN ORDER
Solicitation # SPE2DP-26-R-0002
Solicitation SPE2DP-26-R-0002 is a federal request for a firm-fixed price, indefinite-delivery, indefinite-quantity contract to establish a source of supply for the Influenza Virus Vaccine, Southern Hemisphere 2027 Formula. The contract, issued by the Medical Supply Chain Pharmacy FSA for the Department of Defense, covers a twelve month term for quadrivalent or trivalent vaccines suitable for individuals aged six months and older. The required product consists of 0.5 ML doses provided in packages of ten syringes. All quantities must be delivered to the Defense Distribution Center in Susquehanna, Pennsylvania, by March 31, 2027, with delivery appointments coordinated through DLA Distribution Susquehanna. Proposals must be submitted exclusively via the DLA Internet Bid Board System by October 14, 2026. Evaluation is based on price and the ability to meet all solicitation terms, including the provision of FDA approval for manufacturers or a manufacturer's Letter of Commitment for dealers. The contractor is responsible for ensuring products comply with USP requirements and the Drug Supply Chain Security Act. Strict packaging and marking standards apply, specifically Medical Marking Standard No. 1D, with rigorous cold chain requirements for refrigerated items (2 to 8 degrees Celsius) and frozen items (-25 to -10 degrees Celsius), including the use of DLA-compatible temperature monitors. Invoicing and payment will be processed electronically through the Wide Area Workflow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

15 days ago

DEADLINE

in about 16 hours
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

NAICS: 324110
New
DIBBS
SOLICITATION: SPE605-26-R-0217 (PHILIPPINES, POST, CAMPS, & STATIONS (PC&S) PP 1.6P)
Solicitation # SPE605-26-R-0217
Solicitation SPE605-26-R-0217 is a request for proposal issued by the Defense Logistics Agency Energy for a fixed-price, requirements contract with economic price adjustment to provide various fuel products, distillates, and residuals for Department of Defense sites throughout the Philippines. The procurement covers Diesel Fuel (DF2), Aviation Turbine Fuel (JA1), and Automotive Gasoline (MUP), with an ordering period from January 1, 2027, through December 31, 2029, and a delivery period extending through January 31, 2030. This is an open continuous solicitation, meaning the government may issue amendments to add new line items throughout the performance period. The contract is unrestricted under NAICS code 324110 and utilizes a Lowest Price Technically Acceptable source selection process. Offerors must submit proposals in English and U.S. dollars via the Posts, Camps and Stations Offer Entry Tool, with a final submission deadline of October 19, 2026. Technical requirements include strict adherence to quality assurance provisions, the submission of Certificates of Analysis not older than 90 days, and compliance with MIL-STD-129 for shipment marking. Pricing is based on a reference date of July 13, 2026, and will escalate or de-escalate daily based on prescribed Platts Singapore indices. Deliveries are FOB Destination and must be capable of being executed within 48 hours of the performance start date.
Petroleum Refineries

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS